Tag Archives: U.S.

The obscure advisory committees at the heart of the U.S. drug pricing debate

CHICAGO (Reuters) – Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries. Amgen’s migraine treatment, Aimovig, which has been prescribed to more than 200,000 patients so far is pictured in this undated handout photo obtained by Reuters April 26, 2019.… Read More »

The digital drug: Internet addiction spawns U.S. treatment programs

CINCINNATI (Reuters) – When Danny Reagan was 13, he began exhibiting signs of what doctors usually associate with drug addiction. He became agitated, secretive and withdrew from friends. He had quit baseball and Boy Scouts, and he stopped doing homework and showering. Danny Reagan, at the Lindner Center of Hope’s “Reboot” program, which admits only… Read More »